Cardiovascular events in patients receiving immuno-oncology agents, in phase I clinical trials: CAVIO study.
Year: 2024
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Paola Zagami, Eleonora Nicolò, Dario Trapani, Luca Boscolo Bielo, Carmine Valenza, Ambra Carnevale Schianca, Gloria Pellizzari, Grazia Castellano, Sara Gandini, Silvano Vignati, Maria Angela Massaro, Chiara Busacca, Antonio Marra, Beatrice Taurelli Salimbeni, Carmen Belli, Ida Minchella, Marzia Adelia Locatelli, Angela Esposito, Carmen Criscitiello, Giuseppe Curigliano
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: cardiovascular events, immune checkpoint inhibitors, hypertension, thrombosis, myocarditis, anticoagulant use, overall survival, progression-free survival, performance status, cardiovascular risk factors, breast cancer, cancer immunotherapy safety, ECOG performance status, anticoagulation duration
Open Access status: closed
OpenAlex ID: W4399345686
